nodes	percent_of_prediction	percent_of_DWPC	metapath
Theophylline—CYP1A1—Dacarbazine—muscle cancer	0.148	0.201	CbGbCtD
Theophylline—CYP2E1—Dacarbazine—muscle cancer	0.114	0.156	CbGbCtD
Theophylline—CYP1B1—Doxorubicin—muscle cancer	0.113	0.153	CbGbCtD
Theophylline—SLC22A7—Methotrexate—muscle cancer	0.0988	0.134	CbGbCtD
Theophylline—CYP1A2—Dacarbazine—muscle cancer	0.0662	0.09	CbGbCtD
Theophylline—CYP2E1—Etoposide—muscle cancer	0.056	0.0761	CbGbCtD
Theophylline—CYP2C8—Etoposide—muscle cancer	0.0418	0.0569	CbGbCtD
Theophylline—CYP1A2—Etoposide—muscle cancer	0.0324	0.044	CbGbCtD
Theophylline—CYP3A4—Vincristine—muscle cancer	0.0185	0.0252	CbGbCtD
Theophylline—CYP2D6—Doxorubicin—muscle cancer	0.0182	0.0247	CbGbCtD
Theophylline—CYP3A4—Etoposide—muscle cancer	0.017	0.0231	CbGbCtD
Theophylline—CYP3A4—Doxorubicin—muscle cancer	0.0116	0.0157	CbGbCtD
Theophylline—HDAC2—Teniposide—Etoposide—muscle cancer	0.00518	1	CbGdCrCtD
Theophylline—ADORA2B—smooth muscle tissue—muscle cancer	0.00295	0.0282	CbGeAlD
Theophylline—HDAC2—embryo—muscle cancer	0.00266	0.0255	CbGeAlD
Theophylline—ADA—renal system—muscle cancer	0.00259	0.0248	CbGeAlD
Theophylline—PDE3B—bone marrow—muscle cancer	0.00259	0.0248	CbGeAlD
Theophylline—SLC22A7—renal system—muscle cancer	0.00234	0.0224	CbGeAlD
Theophylline—PDE5A—smooth muscle tissue—muscle cancer	0.00223	0.0214	CbGeAlD
Theophylline—PDE4D—tendon—muscle cancer	0.00223	0.0214	CbGeAlD
Theophylline—PDE3B—testis—muscle cancer	0.00221	0.0212	CbGeAlD
Theophylline—PDE3A—smooth muscle tissue—muscle cancer	0.00217	0.0208	CbGeAlD
Theophylline—PDE4C—head—muscle cancer	0.00217	0.0208	CbGeAlD
Theophylline—PDE5A—renal system—muscle cancer	0.00215	0.0206	CbGeAlD
Theophylline—HDAC2—smooth muscle tissue—muscle cancer	0.00209	0.02	CbGeAlD
Theophylline—ADORA2B—vagina—muscle cancer	0.00205	0.0197	CbGeAlD
Theophylline—Inappropriate antidiuretic hormone secretion—Vincristine—muscle cancer	0.00204	0.0343	CcSEcCtD
Theophylline—ADORA1—renal system—muscle cancer	0.00204	0.0195	CbGeAlD
Theophylline—ADA—tendon—muscle cancer	0.00202	0.0194	CbGeAlD
Theophylline—HDAC2—renal system—muscle cancer	0.00201	0.0193	CbGeAlD
Theophylline—ADA—bone marrow—muscle cancer	0.00196	0.0188	CbGeAlD
Theophylline—ADORA2B—head—muscle cancer	0.0019	0.0182	CbGeAlD
Theophylline—ADA—vagina—muscle cancer	0.00188	0.018	CbGeAlD
Theophylline—PDE3A—cardiac atrium—muscle cancer	0.00187	0.0179	CbGeAlD
Theophylline—PDE4D—testis—muscle cancer	0.00185	0.0177	CbGeAlD
Theophylline—ADORA2B—testis—muscle cancer	0.00183	0.0176	CbGeAlD
Theophylline—ADORA1—cardiac atrium—muscle cancer	0.00182	0.0175	CbGeAlD
Theophylline—ADA—head—muscle cancer	0.00173	0.0166	CbGeAlD
Theophylline—PDE5A—tendon—muscle cancer	0.00168	0.0161	CbGeAlD
Theophylline—ADA—testis—muscle cancer	0.00168	0.0161	CbGeAlD
Theophylline—PDE4A—testis—muscle cancer	0.00163	0.0156	CbGeAlD
Theophylline—PDE3A—tendon—muscle cancer	0.00163	0.0156	CbGeAlD
Theophylline—ADORA1—tendon—muscle cancer	0.00159	0.0152	CbGeAlD
Theophylline—ADORA2A—head—muscle cancer	0.00158	0.0151	CbGeAlD
Theophylline—HDAC2—tendon—muscle cancer	0.00157	0.015	CbGeAlD
Theophylline—PDE5A—vagina—muscle cancer	0.00156	0.0149	CbGeAlD
Theophylline—ADORA2A—testis—muscle cancer	0.00152	0.0146	CbGeAlD
Theophylline—Extravasation—Dactinomycin—muscle cancer	0.00152	0.0256	CcSEcCtD
Theophylline—HDAC2—bone marrow—muscle cancer	0.00152	0.0146	CbGeAlD
Theophylline—SLC22A7—testis—muscle cancer	0.00151	0.0145	CbGeAlD
Theophylline—ADORA1—vagina—muscle cancer	0.00148	0.0141	CbGeAlD
Theophylline—HDAC2—vagina—muscle cancer	0.00146	0.014	CbGeAlD
Theophylline—PDE5A—head—muscle cancer	0.00144	0.0138	CbGeAlD
Theophylline—PDE5A—testis—muscle cancer	0.00139	0.0133	CbGeAlD
Theophylline—ADORA1—head—muscle cancer	0.00136	0.0131	CbGeAlD
Theophylline—Extravasation—Vincristine—muscle cancer	0.00136	0.0228	CcSEcCtD
Theophylline—PDE3A—testis—muscle cancer	0.00135	0.0129	CbGeAlD
Theophylline—PDE4B—cardiac atrium—muscle cancer	0.00135	0.0129	CbGeAlD
Theophylline—HDAC2—head—muscle cancer	0.00135	0.0129	CbGeAlD
Theophylline—CYP1B1—smooth muscle tissue—muscle cancer	0.00134	0.0129	CbGeAlD
Theophylline—ADORA1—testis—muscle cancer	0.00132	0.0126	CbGeAlD
Theophylline—HDAC2—testis—muscle cancer	0.0013	0.0125	CbGeAlD
Theophylline—CYP1B1—renal system—muscle cancer	0.00129	0.0124	CbGeAlD
Theophylline—Hyperuricaemia—Vincristine—muscle cancer	0.00128	0.0215	CcSEcCtD
Theophylline—Sinus tachycardia—Doxorubicin—muscle cancer	0.00124	0.0208	CcSEcCtD
Theophylline—Blood uric acid increased—Vincristine—muscle cancer	0.00121	0.0203	CcSEcCtD
Theophylline—PDE4B—tendon—muscle cancer	0.00118	0.0113	CbGeAlD
Theophylline—PDE4B—bone marrow—muscle cancer	0.00114	0.0109	CbGeAlD
Theophylline—Phlebitis—Dactinomycin—muscle cancer	0.00112	0.0188	CcSEcCtD
Theophylline—Extravasation—Etoposide—muscle cancer	0.0011	0.0185	CcSEcCtD
Theophylline—PDE4B—vagina—muscle cancer	0.00109	0.0105	CbGeAlD
Theophylline—Coma—Vincristine—muscle cancer	0.00109	0.0182	CcSEcCtD
Theophylline—Hyperuricaemia—Etoposide—muscle cancer	0.00104	0.0174	CcSEcCtD
Theophylline—PDE4B—head—muscle cancer	0.00101	0.00966	CbGeAlD
Theophylline—CYP1B1—tendon—muscle cancer	0.00101	0.00966	CbGeAlD
Theophylline—CYP2C8—renal system—muscle cancer	0.000989	0.00948	CbGeAlD
Theophylline—Polyuria—Vincristine—muscle cancer	0.000982	0.0165	CcSEcCtD
Theophylline—Blood uric acid increased—Etoposide—muscle cancer	0.00098	0.0164	CcSEcCtD
Theophylline—PDE4B—testis—muscle cancer	0.000974	0.00933	CbGeAlD
Theophylline—CYP1A2—renal system—muscle cancer	0.000925	0.00887	CbGeAlD
Theophylline—Venous thrombosis—Doxorubicin—muscle cancer	0.000925	0.0155	CcSEcCtD
Theophylline—CYP1A1—renal system—muscle cancer	0.000913	0.00875	CbGeAlD
Theophylline—CYP1B1—head—muscle cancer	0.000864	0.00828	CbGeAlD
Theophylline—CYP1B1—testis—muscle cancer	0.000835	0.008	CbGeAlD
Theophylline—CYP2E1—renal system—muscle cancer	0.000832	0.00798	CbGeAlD
Theophylline—Haematemesis—Methotrexate—muscle cancer	0.00083	0.0139	CcSEcCtD
Theophylline—Urinary retention—Vincristine—muscle cancer	0.00082	0.0138	CcSEcCtD
Theophylline—CYP1A1—cardiac atrium—muscle cancer	0.000817	0.00783	CbGeAlD
Theophylline—Phlebitis—Etoposide—muscle cancer	0.000811	0.0136	CcSEcCtD
Theophylline—Anaphylactoid reaction—Etoposide—muscle cancer	0.000722	0.0121	CcSEcCtD
Theophylline—Haematemesis—Doxorubicin—muscle cancer	0.000718	0.0121	CcSEcCtD
Theophylline—Hypercalcaemia—Doxorubicin—muscle cancer	0.000718	0.0121	CcSEcCtD
Theophylline—CYP2C8—vagina—muscle cancer	0.000716	0.00686	CbGeAlD
Theophylline—Ventricular arrhythmia—Doxorubicin—muscle cancer	0.000674	0.0113	CcSEcCtD
Theophylline—CYP3A4—renal system—muscle cancer	0.00067	0.00642	CbGeAlD
Theophylline—Albuminuria—Doxorubicin—muscle cancer	0.000668	0.0112	CcSEcCtD
Theophylline—CYP1A1—vagina—muscle cancer	0.000661	0.00634	CbGeAlD
Theophylline—Extravasation—Methotrexate—muscle cancer	0.000661	0.0111	CcSEcCtD
Theophylline—CYP2D6—renal system—muscle cancer	0.000659	0.00632	CbGeAlD
Theophylline—CYP2E1—tendon—muscle cancer	0.00065	0.00623	CbGeAlD
Theophylline—CYP2C8—testis—muscle cancer	0.000639	0.00612	CbGeAlD
Theophylline—Hyperuricaemia—Methotrexate—muscle cancer	0.000621	0.0104	CcSEcCtD
Theophylline—Flushing—Dactinomycin—muscle cancer	0.00062	0.0104	CcSEcCtD
Theophylline—CYP1A1—head—muscle cancer	0.000611	0.00585	CbGeAlD
Theophylline—Alopecia—Dactinomycin—muscle cancer	0.00059	0.0099	CcSEcCtD
Theophylline—Blood uric acid increased—Methotrexate—muscle cancer	0.000587	0.00985	CcSEcCtD
Theophylline—Extravasation—Doxorubicin—muscle cancer	0.000572	0.0096	CcSEcCtD
Theophylline—CYP2E1—head—muscle cancer	0.000557	0.00534	CbGeAlD
Theophylline—Ventricular extrasystoles—Doxorubicin—muscle cancer	0.000553	0.00927	CcSEcCtD
Theophylline—CYP2E1—testis—muscle cancer	0.000538	0.00516	CbGeAlD
Theophylline—Hyperuricaemia—Doxorubicin—muscle cancer	0.000538	0.00903	CcSEcCtD
Theophylline—Alopecia—Vincristine—muscle cancer	0.000527	0.00884	CcSEcCtD
Theophylline—Coma—Methotrexate—muscle cancer	0.000527	0.00884	CcSEcCtD
Theophylline—Blood uric acid increased—Doxorubicin—muscle cancer	0.000508	0.00853	CcSEcCtD
Theophylline—Dermatitis contact—Doxorubicin—muscle cancer	0.000493	0.00828	CcSEcCtD
Theophylline—Agitation—Vincristine—muscle cancer	0.000477	0.00801	CcSEcCtD
Theophylline—Polyuria—Methotrexate—muscle cancer	0.000476	0.00799	CcSEcCtD
Theophylline—Infection—Dactinomycin—muscle cancer	0.000471	0.00791	CcSEcCtD
Theophylline—Coma—Doxorubicin—muscle cancer	0.000456	0.00765	CcSEcCtD
Theophylline—Anorexia—Dactinomycin—muscle cancer	0.000452	0.00759	CcSEcCtD
Theophylline—Convulsion—Vincristine—muscle cancer	0.00045	0.00755	CcSEcCtD
Theophylline—Flushing—Etoposide—muscle cancer	0.000448	0.00752	CcSEcCtD
Theophylline—Dermatitis exfoliative—Methotrexate—muscle cancer	0.000443	0.00744	CcSEcCtD
Theophylline—CYP2D6—head—muscle cancer	0.000441	0.00423	CbGeAlD
Theophylline—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000432	0.00725	CcSEcCtD
Theophylline—Alopecia—Etoposide—muscle cancer	0.000427	0.00716	CcSEcCtD
Theophylline—CYP2D6—testis—muscle cancer	0.000426	0.00408	CbGeAlD
Theophylline—Anaphylactic shock—Vincristine—muscle cancer	0.000424	0.00711	CcSEcCtD
Theophylline—Infection—Vincristine—muscle cancer	0.000421	0.00706	CcSEcCtD
Theophylline—Phlebitis—Doxorubicin—muscle cancer	0.000421	0.00706	CcSEcCtD
Theophylline—Nervous system disorder—Vincristine—muscle cancer	0.000416	0.00697	CcSEcCtD
Theophylline—Decreased appetite—Dactinomycin—muscle cancer	0.000412	0.00692	CcSEcCtD
Theophylline—Anorexia—Vincristine—muscle cancer	0.000404	0.00678	CcSEcCtD
Theophylline—Irritability—Methotrexate—muscle cancer	0.000399	0.0067	CcSEcCtD
Theophylline—Hypotension—Vincristine—muscle cancer	0.000396	0.00664	CcSEcCtD
Theophylline—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000388	0.00651	CcSEcCtD
Theophylline—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000384	0.00644	CcSEcCtD
Theophylline—Insomnia—Vincristine—muscle cancer	0.000383	0.00643	CcSEcCtD
Theophylline—Abdominal pain—Dactinomycin—muscle cancer	0.000375	0.00629	CcSEcCtD
Theophylline—Body temperature increased—Dactinomycin—muscle cancer	0.000375	0.00629	CcSEcCtD
Theophylline—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000374	0.00628	CcSEcCtD
Theophylline—Decreased appetite—Vincristine—muscle cancer	0.000368	0.00618	CcSEcCtD
Theophylline—Convulsion—Etoposide—muscle cancer	0.000364	0.00612	CcSEcCtD
Theophylline—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—muscle cancer	0.000354	0.00373	CbGpPWpGaD
Theophylline—CYP1B1—Tryptophan metabolism—MDM2—muscle cancer	0.000351	0.0037	CbGpPWpGaD
Theophylline—Hypersensitivity—Dactinomycin—muscle cancer	0.000349	0.00586	CcSEcCtD
Theophylline—Gastrointestinal pain—Vincristine—muscle cancer	0.000347	0.00581	CcSEcCtD
Theophylline—Anaphylactic shock—Etoposide—muscle cancer	0.000343	0.00576	CcSEcCtD
Theophylline—Infection—Etoposide—muscle cancer	0.000341	0.00572	CcSEcCtD
Theophylline—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	0.000339	0.00357	CbGpPWpGaD
Theophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—FOXO4—muscle cancer	0.000338	0.00356	CbGpPWpGaD
Theophylline—HDAC2—Glucocorticoid receptor regulatory network—MDM2—muscle cancer	0.000337	0.00355	CbGpPWpGaD
Theophylline—Tachycardia—Etoposide—muscle cancer	0.000335	0.00562	CcSEcCtD
Theophylline—Body temperature increased—Vincristine—muscle cancer	0.000335	0.00562	CcSEcCtD
Theophylline—Abdominal pain—Vincristine—muscle cancer	0.000335	0.00562	CcSEcCtD
Theophylline—CYP1A2—Melatonin metabolism and effects—FOXO1—muscle cancer	0.000332	0.0035	CbGpPWpGaD
Theophylline—Abdominal pain upper—Doxorubicin—muscle cancer	0.000331	0.00555	CcSEcCtD
Theophylline—Hypokalaemia—Doxorubicin—muscle cancer	0.00033	0.00553	CcSEcCtD
Theophylline—Anorexia—Etoposide—muscle cancer	0.000327	0.00549	CcSEcCtD
Theophylline—CYP1A1—PPARA activates gene expression—MED12—muscle cancer	0.000327	0.00345	CbGpPWpGaD
Theophylline—ADORA2B—GPCR ligand binding—PTCH1—muscle cancer	0.000326	0.00344	CbGpPWpGaD
Theophylline—Diarrhoea—Dactinomycin—muscle cancer	0.000325	0.00545	CcSEcCtD
Theophylline—Hypotension—Etoposide—muscle cancer	0.000321	0.00538	CcSEcCtD
Theophylline—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—muscle cancer	0.00032	0.00337	CbGpPWpGaD
Theophylline—CYP1B1—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000317	0.00334	CbGpPWpGaD
Theophylline—Hypersensitivity—Vincristine—muscle cancer	0.000312	0.00524	CcSEcCtD
Theophylline—Haematuria—Methotrexate—muscle cancer	0.000307	0.00516	CcSEcCtD
Theophylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000307	0.00324	CbGpPWpGaD
Theophylline—PDE5A—Hemostasis—IGF2—muscle cancer	0.000302	0.00318	CbGpPWpGaD
Theophylline—Vomiting—Dactinomycin—muscle cancer	0.000302	0.00506	CcSEcCtD
Theophylline—Rash—Dactinomycin—muscle cancer	0.000299	0.00502	CcSEcCtD
Theophylline—Decreased appetite—Etoposide—muscle cancer	0.000298	0.00501	CcSEcCtD
Theophylline—HDAC2—Hemostasis—ANGPT2—muscle cancer	0.000292	0.00308	CbGpPWpGaD
Theophylline—HDAC2—Cell Cycle—CDKN2A—muscle cancer	0.000291	0.00307	CbGpPWpGaD
Theophylline—Diarrhoea—Vincristine—muscle cancer	0.00029	0.00487	CcSEcCtD
Theophylline—HDAC2—Cell Cycle—MDM2—muscle cancer	0.000283	0.00298	CbGpPWpGaD
Theophylline—Hyperglycaemia—Doxorubicin—muscle cancer	0.000282	0.00474	CcSEcCtD
Theophylline—Nausea—Dactinomycin—muscle cancer	0.000282	0.00473	CcSEcCtD
Theophylline—Gastrointestinal pain—Etoposide—muscle cancer	0.000281	0.00471	CcSEcCtD
Theophylline—Dizziness—Vincristine—muscle cancer	0.00028	0.0047	CcSEcCtD
Theophylline—HDAC2—Signaling by NGF—FOXO4—muscle cancer	0.00028	0.00295	CbGpPWpGaD
Theophylline—ADORA1—GPCR ligand binding—PTCH1—muscle cancer	0.000277	0.00292	CbGpPWpGaD
Theophylline—ADORA2A—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000277	0.00292	CbGpPWpGaD
Theophylline—ADA—Metabolism—FH—muscle cancer	0.000277	0.00292	CbGpPWpGaD
Theophylline—ADORA2B—GPCR ligand binding—CNR1—muscle cancer	0.000275	0.0029	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—KIDINS220—muscle cancer	0.000275	0.0029	CbGpPWpGaD
Theophylline—Urticaria—Etoposide—muscle cancer	0.000273	0.00458	CcSEcCtD
Theophylline—Abdominal pain—Etoposide—muscle cancer	0.000271	0.00455	CcSEcCtD
Theophylline—Body temperature increased—Etoposide—muscle cancer	0.000271	0.00455	CcSEcCtD
Theophylline—Vomiting—Vincristine—muscle cancer	0.000269	0.00452	CcSEcCtD
Theophylline—Rash—Vincristine—muscle cancer	0.000267	0.00448	CcSEcCtD
Theophylline—Dermatitis—Vincristine—muscle cancer	0.000267	0.00448	CcSEcCtD
Theophylline—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	0.000267	0.00281	CbGpPWpGaD
Theophylline—Haematuria—Doxorubicin—muscle cancer	0.000266	0.00447	CcSEcCtD
Theophylline—Headache—Vincristine—muscle cancer	0.000265	0.00445	CcSEcCtD
Theophylline—ADORA2A—Signaling by NGF—FOXO4—muscle cancer	0.00026	0.00274	CbGpPWpGaD
Theophylline—Alopecia—Methotrexate—muscle cancer	0.000256	0.00429	CcSEcCtD
Theophylline—Hypersensitivity—Etoposide—muscle cancer	0.000253	0.00424	CcSEcCtD
Theophylline—Nausea—Vincristine—muscle cancer	0.000252	0.00422	CcSEcCtD
Theophylline—ADORA2B—Signaling Pathways—KIDINS220—muscle cancer	0.000251	0.00265	CbGpPWpGaD
Theophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—FOXO1—muscle cancer	0.00025	0.00263	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—KIDINS220—muscle cancer	0.000244	0.00257	CbGpPWpGaD
Theophylline—Pruritus—Etoposide—muscle cancer	0.000243	0.00408	CcSEcCtD
Theophylline—PDE4D—Signaling Pathways—KIDINS220—muscle cancer	0.00024	0.00253	CbGpPWpGaD
Theophylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000237	0.0025	CbGpPWpGaD
Theophylline—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000237	0.0025	CbGpPWpGaD
Theophylline—Diarrhoea—Etoposide—muscle cancer	0.000235	0.00394	CcSEcCtD
Theophylline—ADORA1—GPCR ligand binding—CNR1—muscle cancer	0.000234	0.00247	CbGpPWpGaD
Theophylline—Flushing—Doxorubicin—muscle cancer	0.000233	0.0039	CcSEcCtD
Theophylline—CYP2E1—Tryptophan metabolism—MDM2—muscle cancer	0.000229	0.00242	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—KIDINS220—muscle cancer	0.000228	0.0024	CbGpPWpGaD
Theophylline—Dizziness—Etoposide—muscle cancer	0.000227	0.00381	CcSEcCtD
Theophylline—Arrhythmia—Doxorubicin—muscle cancer	0.000224	0.00376	CcSEcCtD
Theophylline—PDE3A—Signaling Pathways—KIDINS220—muscle cancer	0.000222	0.00234	CbGpPWpGaD
Theophylline—Alopecia—Doxorubicin—muscle cancer	0.000221	0.00372	CcSEcCtD
Theophylline—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—muscle cancer	0.00022	0.00232	CbGpPWpGaD
Theophylline—HDAC2—Direct p53 effectors—MDM2—muscle cancer	0.000219	0.00231	CbGpPWpGaD
Theophylline—Convulsion—Methotrexate—muscle cancer	0.000218	0.00366	CcSEcCtD
Theophylline—Vomiting—Etoposide—muscle cancer	0.000218	0.00366	CcSEcCtD
Theophylline—Rash—Etoposide—muscle cancer	0.000216	0.00363	CcSEcCtD
Theophylline—CYP1A1—Tryptophan metabolism—MDM2—muscle cancer	0.000216	0.00228	CbGpPWpGaD
Theophylline—Dermatitis—Etoposide—muscle cancer	0.000216	0.00363	CcSEcCtD
Theophylline—Headache—Etoposide—muscle cancer	0.000215	0.00361	CcSEcCtD
Theophylline—ADORA2A—GPCR ligand binding—PTCH1—muscle cancer	0.000214	0.00226	CbGpPWpGaD
Theophylline—Tension—Doxorubicin—muscle cancer	0.000214	0.00359	CcSEcCtD
Theophylline—ADORA1—Signaling Pathways—KIDINS220—muscle cancer	0.000214	0.00225	CbGpPWpGaD
Theophylline—Nervousness—Doxorubicin—muscle cancer	0.000212	0.00356	CcSEcCtD
Theophylline—PDE4B—Signaling Pathways—KIDINS220—muscle cancer	0.000211	0.00222	CbGpPWpGaD
Theophylline—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	0.000209	0.0022	CbGpPWpGaD
Theophylline—HDAC2—Signaling by NGF—FOXO1—muscle cancer	0.000206	0.00218	CbGpPWpGaD
Theophylline—Anaphylactic shock—Methotrexate—muscle cancer	0.000206	0.00345	CcSEcCtD
Theophylline—Infection—Methotrexate—muscle cancer	0.000204	0.00343	CcSEcCtD
Theophylline—Nausea—Etoposide—muscle cancer	0.000204	0.00342	CcSEcCtD
Theophylline—Nervous system disorder—Methotrexate—muscle cancer	0.000202	0.00338	CcSEcCtD
Theophylline—Agitation—Doxorubicin—muscle cancer	0.0002	0.00336	CcSEcCtD
Theophylline—Anorexia—Methotrexate—muscle cancer	0.000196	0.00329	CcSEcCtD
Theophylline—PDE3B—Hemostasis—IGF2—muscle cancer	0.000195	0.00206	CbGpPWpGaD
Theophylline—CYP1A1—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000195	0.00206	CbGpPWpGaD
Theophylline—HDAC2—Glucocorticoid receptor regulatory network—TP53—muscle cancer	0.000193	0.00204	CbGpPWpGaD
Theophylline—Palpitations—Doxorubicin—muscle cancer	0.000193	0.00324	CcSEcCtD
Theophylline—Hypotension—Methotrexate—muscle cancer	0.000192	0.00322	CcSEcCtD
Theophylline—ADORA2A—Signaling by NGF—FOXO1—muscle cancer	0.000192	0.00202	CbGpPWpGaD
Theophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	0.00019	0.002	CbGpPWpGaD
Theophylline—Convulsion—Doxorubicin—muscle cancer	0.000189	0.00317	CcSEcCtD
Theophylline—Insomnia—Methotrexate—muscle cancer	0.000186	0.00312	CcSEcCtD
Theophylline—Anxiety—Doxorubicin—muscle cancer	0.000185	0.00311	CcSEcCtD
Theophylline—PDE4C—Signaling by GPCR—PTCH1—muscle cancer	0.000183	0.00193	CbGpPWpGaD
Theophylline—ADORA2A—GPCR ligand binding—CNR1—muscle cancer	0.000181	0.0019	CbGpPWpGaD
Theophylline—CYP2C8—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000179	0.00188	CbGpPWpGaD
Theophylline—Decreased appetite—Methotrexate—muscle cancer	0.000179	0.003	CcSEcCtD
Theophylline—Anaphylactic shock—Doxorubicin—muscle cancer	0.000178	0.00299	CcSEcCtD
Theophylline—PDE3A—Hemostasis—IGF2—muscle cancer	0.000178	0.00187	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—KIDINS220—muscle cancer	0.000177	0.00187	CbGpPWpGaD
Theophylline—Infection—Doxorubicin—muscle cancer	0.000177	0.00297	CcSEcCtD
Theophylline—Shock—Doxorubicin—muscle cancer	0.000175	0.00294	CcSEcCtD
Theophylline—Nervous system disorder—Doxorubicin—muscle cancer	0.000175	0.00293	CcSEcCtD
Theophylline—Tachycardia—Doxorubicin—muscle cancer	0.000174	0.00292	CcSEcCtD
Theophylline—PDE4C—GPCR downstream signaling—CNR1—muscle cancer	0.00017	0.0018	CbGpPWpGaD
Theophylline—Anorexia—Doxorubicin—muscle cancer	0.00017	0.00285	CcSEcCtD
Theophylline—Gastrointestinal pain—Methotrexate—muscle cancer	0.000168	0.00282	CcSEcCtD
Theophylline—ADORA2B—Signaling by GPCR—PTCH1—muscle cancer	0.000167	0.00176	CbGpPWpGaD
Theophylline—Hypotension—Doxorubicin—muscle cancer	0.000166	0.00279	CcSEcCtD
Theophylline—ADORA2A—Signaling Pathways—KIDINS220—muscle cancer	0.000165	0.00174	CbGpPWpGaD
Theophylline—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	0.000164	0.00173	CbGpPWpGaD
Theophylline—Urticaria—Methotrexate—muscle cancer	0.000163	0.00274	CcSEcCtD
Theophylline—Body temperature increased—Methotrexate—muscle cancer	0.000163	0.00273	CcSEcCtD
Theophylline—Abdominal pain—Methotrexate—muscle cancer	0.000163	0.00273	CcSEcCtD
Theophylline—PDE3B—Signaling by GPCR—PTCH1—muscle cancer	0.000162	0.00171	CbGpPWpGaD
Theophylline—HDAC2—Cell Cycle—TP53—muscle cancer	0.000162	0.00171	CbGpPWpGaD
Theophylline—Insomnia—Doxorubicin—muscle cancer	0.000161	0.0027	CcSEcCtD
Theophylline—PDE4D—Signaling by GPCR—PTCH1—muscle cancer	0.00016	0.00168	CbGpPWpGaD
Theophylline—HDAC2—Signaling by NGF—KIT—muscle cancer	0.000157	0.00166	CbGpPWpGaD
Theophylline—ADA—Metabolism—MED12—muscle cancer	0.000156	0.00165	CbGpPWpGaD
Theophylline—ADORA2B—GPCR downstream signaling—CNR1—muscle cancer	0.000156	0.00164	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—CNR1—muscle cancer	0.000155	0.00163	CbGpPWpGaD
Theophylline—Decreased appetite—Doxorubicin—muscle cancer	0.000155	0.0026	CcSEcCtD
Theophylline—HDAC2—Signaling by NOTCH—TP53—muscle cancer	0.000154	0.00162	CbGpPWpGaD
Theophylline—ADA—Circadian rythm related genes—TP53—muscle cancer	0.000153	0.00161	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—PTCH1—muscle cancer	0.000152	0.0016	CbGpPWpGaD
Theophylline—Hypersensitivity—Methotrexate—muscle cancer	0.000152	0.00254	CcSEcCtD
Theophylline—PDE3B—GPCR downstream signaling—CNR1—muscle cancer	0.000151	0.00159	CbGpPWpGaD
Theophylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.00015	0.00158	CbGpPWpGaD
Theophylline—PDE4D—GPCR downstream signaling—CNR1—muscle cancer	0.000148	0.00156	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—PTCH1—muscle cancer	0.000148	0.00156	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by NGF—KIT—muscle cancer	0.000146	0.00154	CbGpPWpGaD
Theophylline—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000146	0.00244	CcSEcCtD
Theophylline—CYP2C9—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000146	0.00153	CbGpPWpGaD
Theophylline—Pruritus—Methotrexate—muscle cancer	0.000145	0.00244	CcSEcCtD
Theophylline—ADA—Metabolism—ENO2—muscle cancer	0.000143	0.0015	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000143	0.0015	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—PTCH1—muscle cancer	0.000142	0.0015	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—IGF2—muscle cancer	0.000142	0.0015	CbGpPWpGaD
Theophylline—Urticaria—Doxorubicin—muscle cancer	0.000141	0.00237	CcSEcCtD
Theophylline—ADORA2B—Signaling by GPCR—CNR1—muscle cancer	0.000141	0.00149	CbGpPWpGaD
Theophylline—PDE4A—GPCR downstream signaling—CNR1—muscle cancer	0.000141	0.00149	CbGpPWpGaD
Theophylline—Abdominal pain—Doxorubicin—muscle cancer	0.000141	0.00236	CcSEcCtD
Theophylline—Body temperature increased—Doxorubicin—muscle cancer	0.000141	0.00236	CcSEcCtD
Theophylline—Diarrhoea—Methotrexate—muscle cancer	0.000141	0.00236	CcSEcCtD
Theophylline—PDE4B—Signaling by GPCR—PTCH1—muscle cancer	0.000141	0.00148	CbGpPWpGaD
Theophylline—CYP1A2—Tryptophan metabolism—MDM2—muscle cancer	0.000138	0.00145	CbGpPWpGaD
Theophylline—PDE3A—GPCR downstream signaling—CNR1—muscle cancer	0.000137	0.00145	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—CNR1—muscle cancer	0.000137	0.00144	CbGpPWpGaD
Theophylline—Dizziness—Methotrexate—muscle cancer	0.000136	0.00228	CcSEcCtD
Theophylline—PDE4D—Signaling by GPCR—CNR1—muscle cancer	0.000135	0.00142	CbGpPWpGaD
Theophylline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	0.000133	0.0014	CbGpPWpGaD
Theophylline—ADORA1—GPCR downstream signaling—CNR1—muscle cancer	0.000132	0.00139	CbGpPWpGaD
Theophylline—Hypersensitivity—Doxorubicin—muscle cancer	0.000131	0.0022	CcSEcCtD
Theophylline—Vomiting—Methotrexate—muscle cancer	0.000131	0.00219	CcSEcCtD
Theophylline—PDE4B—GPCR downstream signaling—CNR1—muscle cancer	0.000131	0.00138	CbGpPWpGaD
Theophylline—Rash—Methotrexate—muscle cancer	0.00013	0.00218	CcSEcCtD
Theophylline—Dermatitis—Methotrexate—muscle cancer	0.00013	0.00217	CcSEcCtD
Theophylline—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—muscle cancer	0.000129	0.00136	CbGpPWpGaD
Theophylline—Headache—Methotrexate—muscle cancer	0.000129	0.00216	CcSEcCtD
Theophylline—PDE4A—Signaling by GPCR—CNR1—muscle cancer	0.000128	0.00135	CbGpPWpGaD
Theophylline—PDE5A—Hemostasis—VEGFA—muscle cancer	0.000127	0.00133	CbGpPWpGaD
Theophylline—Pruritus—Doxorubicin—muscle cancer	0.000126	0.00211	CcSEcCtD
Theophylline—HDAC2—Direct p53 effectors—TP53—muscle cancer	0.000126	0.00133	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—CNR1—muscle cancer	0.000125	0.00132	CbGpPWpGaD
Theophylline—CYP1A2—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000124	0.00131	CbGpPWpGaD
Theophylline—HDAC2—Gene Expression—MED12—muscle cancer	0.000124	0.00131	CbGpPWpGaD
Theophylline—HDAC2—Signaling by NGF—MDM2—muscle cancer	0.000124	0.00131	CbGpPWpGaD
Theophylline—Nausea—Methotrexate—muscle cancer	0.000122	0.00205	CcSEcCtD
Theophylline—Diarrhoea—Doxorubicin—muscle cancer	0.000122	0.00204	CcSEcCtD
Theophylline—ADORA1—Signaling by GPCR—CNR1—muscle cancer	0.00012	0.00127	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—CNR1—muscle cancer	0.000119	0.00125	CbGpPWpGaD
Theophylline—Dizziness—Doxorubicin—muscle cancer	0.000118	0.00198	CcSEcCtD
Theophylline—ADORA2A—Signaling by NGF—MDM2—muscle cancer	0.000115	0.00121	CbGpPWpGaD
Theophylline—ADORA1—Circadian rythm related genes—TP53—muscle cancer	0.000113	0.0012	CbGpPWpGaD
Theophylline—Vomiting—Doxorubicin—muscle cancer	0.000113	0.0019	CcSEcCtD
Theophylline—CYP1B1—Metabolism—FH—muscle cancer	0.000112	0.00118	CbGpPWpGaD
Theophylline—Rash—Doxorubicin—muscle cancer	0.000112	0.00188	CcSEcCtD
Theophylline—Dermatitis—Doxorubicin—muscle cancer	0.000112	0.00188	CcSEcCtD
Theophylline—Headache—Doxorubicin—muscle cancer	0.000112	0.00187	CcSEcCtD
Theophylline—ADORA2A—Signaling by GPCR—PTCH1—muscle cancer	0.00011	0.00116	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—PTCH1—muscle cancer	0.000108	0.00114	CbGpPWpGaD
Theophylline—CYP3A4—Tryptophan metabolism—MDM2—muscle cancer	0.000106	0.00112	CbGpPWpGaD
Theophylline—Nausea—Doxorubicin—muscle cancer	0.000106	0.00177	CcSEcCtD
Theophylline—HDAC2—Disease—ENO2—muscle cancer	0.000105	0.00111	CbGpPWpGaD
Theophylline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	0.000105	0.0011	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—CNR1—muscle cancer	0.000102	0.00108	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—PTCH1—muscle cancer	9.89e-05	0.00104	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—PTCH1—muscle cancer	9.59e-05	0.00101	CbGpPWpGaD
Theophylline—HDAC2—Disease—HMGA1—muscle cancer	9.56e-05	0.00101	CbGpPWpGaD
Theophylline—PDE5A—Hemostasis—TP53—muscle cancer	9.56e-05	0.00101	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—PTCH1—muscle cancer	9.43e-05	0.000994	CbGpPWpGaD
Theophylline—HDAC2—Circadian rythm related genes—TP53—muscle cancer	9.43e-05	0.000993	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—FOXO4—muscle cancer	9.32e-05	0.000982	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—CNR1—muscle cancer	9.28e-05	0.000977	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—CNR1—muscle cancer	9.15e-05	0.000964	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—PTCH1—muscle cancer	8.98e-05	0.000946	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	8.78e-05	0.000925	CbGpPWpGaD
Theophylline—ADORA2A—Circadian rythm related genes—TP53—muscle cancer	8.76e-05	0.000924	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—PTCH1—muscle cancer	8.73e-05	0.00092	CbGpPWpGaD
Theophylline—HDAC2—Disease—FOXO4—muscle cancer	8.57e-05	0.000904	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—FOXO4—muscle cancer	8.5e-05	0.000896	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—PTCH1—muscle cancer	8.41e-05	0.000886	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—CNR1—muscle cancer	8.35e-05	0.00088	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—PTCH1—muscle cancer	8.31e-05	0.000875	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—FOXO4—muscle cancer	8.25e-05	0.000869	CbGpPWpGaD
Theophylline—PDE3B—Hemostasis—VEGFA—muscle cancer	8.19e-05	0.000863	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—FOXO4—muscle cancer	8.11e-05	0.000855	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—CNR1—muscle cancer	8.09e-05	0.000853	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—MED12—muscle cancer	8.05e-05	0.000848	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—CNR1—muscle cancer	7.96e-05	0.000839	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—FOXO4—muscle cancer	7.72e-05	0.000814	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CNR1—muscle cancer	7.58e-05	0.000799	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—FOXO4—muscle cancer	7.51e-05	0.000792	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—IGF2—muscle cancer	7.48e-05	0.000788	CbGpPWpGaD
Theophylline—PDE3A—Hemostasis—VEGFA—muscle cancer	7.46e-05	0.000786	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CNR1—muscle cancer	7.37e-05	0.000777	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—FH—muscle cancer	7.34e-05	0.000773	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—FOXO4—muscle cancer	7.23e-05	0.000762	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—FOXO4—muscle cancer	7.14e-05	0.000753	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CNR1—muscle cancer	7.1e-05	0.000748	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CNR1—muscle cancer	7.01e-05	0.000739	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PTCH1—muscle cancer	6.98e-05	0.000736	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—FH—muscle cancer	6.92e-05	0.000729	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—FOXO1—muscle cancer	6.88e-05	0.000725	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—IGF2—muscle cancer	6.82e-05	0.000719	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—IGF2—muscle cancer	6.62e-05	0.000697	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	6.55e-05	0.00069	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—IGF2—muscle cancer	6.51e-05	0.000686	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PTCH1—muscle cancer	6.49e-05	0.000684	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—MED12—muscle cancer	6.35e-05	0.000669	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—FH—muscle cancer	6.34e-05	0.000669	CbGpPWpGaD
Theophylline—HDAC2—Disease—FOXO1—muscle cancer	6.33e-05	0.000667	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—FOXO1—muscle cancer	6.28e-05	0.000662	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—IGF2—muscle cancer	6.2e-05	0.000653	CbGpPWpGaD
Theophylline—PDE3B—Hemostasis—TP53—muscle cancer	6.19e-05	0.000652	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—FOXO1—muscle cancer	6.09e-05	0.000642	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—IGF2—muscle cancer	6.03e-05	0.000635	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—FOXO4—muscle cancer	6e-05	0.000633	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—FOXO1—muscle cancer	5.99e-05	0.000631	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—VEGFA—muscle cancer	5.96e-05	0.000628	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CNR1—muscle cancer	5.89e-05	0.000621	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—IGF2—muscle cancer	5.8e-05	0.000611	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—ENO2—muscle cancer	5.79e-05	0.00061	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—IGF2—muscle cancer	5.73e-05	0.000604	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—FOXO1—muscle cancer	5.7e-05	0.000601	CbGpPWpGaD
Theophylline—PDE3A—Hemostasis—TP53—muscle cancer	5.63e-05	0.000594	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	5.6e-05	0.00059	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—FOXO4—muscle cancer	5.58e-05	0.000588	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—FOXO1—muscle cancer	5.55e-05	0.000585	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CNR1—muscle cancer	5.48e-05	0.000577	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—FOXO1—muscle cancer	5.34e-05	0.000563	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—FOXO1—muscle cancer	5.28e-05	0.000556	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—KIT—muscle cancer	5.24e-05	0.000553	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—FH—muscle cancer	5.21e-05	0.000549	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—FH—muscle cancer	5.16e-05	0.000544	CbGpPWpGaD
Theophylline—ADA—Metabolism—PTGS2—muscle cancer	4.97e-05	0.000523	CbGpPWpGaD
Theophylline—HDAC2—Disease—KIT—muscle cancer	4.83e-05	0.000508	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IGF2—muscle cancer	4.82e-05	0.000508	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—KIT—muscle cancer	4.78e-05	0.000504	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—KIT—muscle cancer	4.64e-05	0.000489	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—KIT—muscle cancer	4.56e-05	0.000481	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.53e-05	0.000477	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—TP53—muscle cancer	4.5e-05	0.000475	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IGF2—muscle cancer	4.48e-05	0.000472	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—FOXO1—muscle cancer	4.43e-05	0.000467	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—FH—muscle cancer	4.41e-05	0.000465	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—KIT—muscle cancer	4.34e-05	0.000458	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—KIT—muscle cancer	4.23e-05	0.000445	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—MED12—muscle cancer	4.15e-05	0.000437	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—MDM2—muscle cancer	4.13e-05	0.000435	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—FOXO1—muscle cancer	4.12e-05	0.000434	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—KIT—muscle cancer	4.07e-05	0.000429	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—KIT—muscle cancer	4.02e-05	0.000424	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—MED12—muscle cancer	3.91e-05	0.000412	CbGpPWpGaD
Theophylline—HDAC2—Disease—MDM2—muscle cancer	3.8e-05	0.0004	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—ENO2—muscle cancer	3.78e-05	0.000398	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—MDM2—muscle cancer	3.77e-05	0.000397	CbGpPWpGaD
Theophylline—HDAC2—Disease—PTGS2—muscle cancer	3.66e-05	0.000386	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—MDM2—muscle cancer	3.65e-05	0.000385	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—MDM2—muscle cancer	3.59e-05	0.000379	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—MED12—muscle cancer	3.58e-05	0.000378	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—ENO2—muscle cancer	3.56e-05	0.000376	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—MDM2—muscle cancer	3.42e-05	0.000361	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—FH—muscle cancer	3.4e-05	0.000359	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—KIT—muscle cancer	3.38e-05	0.000356	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—MDM2—muscle cancer	3.33e-05	0.000351	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ENO2—muscle cancer	3.27e-05	0.000344	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—MDM2—muscle cancer	3.2e-05	0.000338	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—MDM2—muscle cancer	3.17e-05	0.000334	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—KIT—muscle cancer	3.14e-05	0.000331	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—VEGFA—muscle cancer	3.14e-05	0.00033	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—MED12—muscle cancer	2.94e-05	0.00031	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—MED12—muscle cancer	2.92e-05	0.000307	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—VEGFA—muscle cancer	2.86e-05	0.000302	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.79e-05	0.000294	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—VEGFA—muscle cancer	2.78e-05	0.000292	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—VEGFA—muscle cancer	2.73e-05	0.000288	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ENO2—muscle cancer	2.68e-05	0.000283	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MDM2—muscle cancer	2.66e-05	0.00028	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ENO2—muscle cancer	2.66e-05	0.00028	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—VEGFA—muscle cancer	2.6e-05	0.000274	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.56e-05	0.000269	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—VEGFA—muscle cancer	2.53e-05	0.000266	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—MED12—muscle cancer	2.49e-05	0.000263	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MDM2—muscle cancer	2.47e-05	0.000261	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—VEGFA—muscle cancer	2.43e-05	0.000256	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—VEGFA—muscle cancer	2.4e-05	0.000253	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—TP53—muscle cancer	2.37e-05	0.00025	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ENO2—muscle cancer	2.27e-05	0.00024	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—TP53—muscle cancer	2.16e-05	0.000228	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—TP53—muscle cancer	2.1e-05	0.000221	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.08e-05	0.000219	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—TP53—muscle cancer	2.06e-05	0.000217	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—VEGFA—muscle cancer	2.02e-05	0.000213	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PTGS2—muscle cancer	2.02e-05	0.000212	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TP53—muscle cancer	1.96e-05	0.000207	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—MED12—muscle cancer	1.92e-05	0.000203	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TP53—muscle cancer	1.91e-05	0.000201	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—VEGFA—muscle cancer	1.88e-05	0.000198	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TP53—muscle cancer	1.84e-05	0.000194	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TP53—muscle cancer	1.82e-05	0.000191	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.78e-05	0.000187	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ENO2—muscle cancer	1.75e-05	0.000185	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TP53—muscle cancer	1.53e-05	0.000161	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TP53—muscle cancer	1.42e-05	0.00015	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PTGS2—muscle cancer	1.32e-05	0.000139	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PTGS2—muscle cancer	1.24e-05	0.000131	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PTGS2—muscle cancer	1.14e-05	0.00012	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PTGS2—muscle cancer	9.34e-06	9.85e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PTGS2—muscle cancer	9.26e-06	9.76e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PTGS2—muscle cancer	7.92e-06	8.34e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PTGS2—muscle cancer	6.11e-06	6.44e-05	CbGpPWpGaD
